Tag: BA.2.75 pathogenicity
WHO: BA.2.75 has more efficient replication in lung cells, fusogenicity, pathogenicity
WHO: “Preliminary laboratory-based studies indicate a relative growth advantage of BA.2.75 as compared to BA.2 and BA.5. More...
WHO: “Preliminary laboratory-based studies indicate a relative growth advantage of BA.2.75 as compared to BA.2 and BA.5. More...